This picture shows a child receiving the Covid-19 vaccine in Xiamen, in eastern China’s Fujian province.
- EU Commissioner approved Pfizer-BioNTech’s Covid-19 vaccine for children aged 5 to 11 years.
- Europe is grappling with an epidemic of disease, resulting in at least half the cases of death and death.
- Vaccination of children is considered to be an important part of the fight against the epidemic.
EU health regulator approved the use of Pfizer-BioNTech’s Covid-19 vaccine for children between the ages of 5 and 11 on Thursday, and opened the way for the first shot as Europe struggles with surgery.
The European Medicines Agency (EMA) has recommended that the Pfizer-BioNTech vaccine, approved for use in the European Union for young people between the ages of 12 and 17 from May, be given as an injection into the upper arm at a dose of 10 micrograms, three weeks apart. The adult dose is 30 micrograms.
The crisis comes as Europe is in the throes of another epidemic, with half of all cases reported dead.
Placement of children and adolescents, who may inadvertently transmit Covid-19 to others, is considered an essential part of coping with the epidemic. In Germany and the Netherlands, children now have the highest number of crimes.
Pfizer and BioNTech say their vaccine, called Comirnaty, showed 90.7% of anti-coronavirus activity in clinical trials for 5- to 11-year-old children.
“The benefits of Comirnaty in children aged 5 to 11 outweigh the risks, especially in those with conditions that increase the risk of Covid-19,” the EMA said.
Although the final approval is in the European Commission, it usually follows the EMA’s opinion and an EU source told Reuters the idea could come up on Friday.
“Modern ideas (…) make it clear that the BioNTech-Pfizer vaccine is safe and effective for young children, and can provide them with extra protection,” EU health chief Stella Kyriakides said on Twitter.
Countries will not be able to launch new baby shots until next month. The first case of low birth weight children will be released on December 20, a BioNTech spokesman said.
Poland’s Ministry of Health spokesman Wojciech Andrusiewicz told state news agency PAP that Poland would begin vaccinating children aged 5-11 in December after receiving the first 1.1 million dose for young children.
The EU enters many countries, including the United States, Canada, Israel, China and Saudi Arabia, which have abolished the vaccine for children aged 5-11 and under.
Millions of middle-aged children this age will be eligible to shoot in the EU. Germany will receive $ 2.4 million for the first delivery, enough to produce half of children aged 5-11, BioNTech said.
The Czech Republic government says it expects to receive Rs 300,000, which would give about one-fifth of its young population.
During the shooting, a U.S. official approved a new vaccine, which uses a new buffer and allows it to be stored in the refrigerator for up to 10 weeks.
The World Health Organization said Wednesday that since children and adolescents are at low risk of Covid-19, countries should prioritize adults and share the dose with the Covax program which aims to provide the world’s poorest countries with limited access to vaccination.
The growing number of lawsuits in Europe has led to the emergence of new unsafe winter routes and people gathering in homes to celebrate Christmas, providing the ideal conditions for COVID-19 to spread.
Slovakia began a two-week closure on Thursday, following Austrian leadership, with Portuguese and French governments considering additional sanctions.
Although health experts are pushing for more effective antiretroviral therapy to try to prevent hospitals from being eradicated because past safety is declining, youth vaccination is another tool to fight the virus.
Some countries, however, have reduced the use of COVID-19 compounds based on the MRNA-specific technology used by Pfizer-BioNTech in adolescents after reports of cardiac complications.
U.S. Head of Infectious Diseases Anthony Fauci told Reuters this week that there were no signs of new immunity since the vaccination of young children began earlier this month.
About 10% of the 28 million eligible children in the US received the first dose.
Original Article reposted fromSource link
Disclaimer: The website autopost contents from credible news sources and we are not the original creators. If we Have added some content that belongs to you or your organization by mistake, We are sorry for that. We apologize for that and assure you that this won’t be repeated in future. If you are the rightful owner of the content used in our Website, please mail us with your Name, Organization Name, Contact Details, Copyright infringing URL and Copyright Proof (URL or Legal Document) aT spacksdigital @ gmail.com
I assure you that, I will remove the infringing content Within 48 Hours.